Health Care & Life Sciences » Biotechnology | Prostemics Co. Ltd.

Prostemics Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
10,058
10,466
14,835
14,164
6,565
Cost of Goods Sold (COGS) incl. D&A
4,013
3,594
3,235
3,646
3,685
Gross Income
6,045
6,872
11,600
10,518
2,879
SG&A Expense
4,464
3,224
5,718
6,405
6,926
EBIT
1,582
3,648
5,881
4,008
4,198
Unusual Expense
-
-
13,772
151
17
Non Operating Income/Expense
154
212
246
515
537
Interest Expense
219
165
143
21
-
Pretax Income
1,247
3,427
7,690
4,849
4,535
Income Tax
1,132
536
827
536
1,377
Consolidated Net Income
2,380
2,890
8,517
4,313
3,158
Net Income
2,380
2,890
8,517
4,313
3,158
Net Income After Extraordinaries
2,380
2,890
8,517
4,313
3,158
Net Income Available to Common
2,380
2,890
8,517
4,313
3,158
EPS (Basic)
222.00
263.00
237.00
98.00
70.00
Basic Shares Outstanding
11
11
36
44
45
EPS (Diluted)
219.00
274.74
237.10
93.91
70.26
Diluted Shares Outstanding
11
11
36
46
45
EBITDA
-
-
6,436
4,965
2,814
Other Operating Expense
-
-
-
105
151
Non-Operating Interest Income
38
156
97
195
336
Equity in Affiliates (Pretax)
-
-
-
-
119

About Prostemics Co.

View Profile
Address
3-4/F, Kyungwon Building
Seoul SL 06061
Korea, Republic Of
Employees -
Website http://www.prostemics.co.kr
Updated 09/14/2018
PROSTEMICS Co., Ltd. engages in the provision of stem cell cosmetics and medicine. It operates through cosmetic and stem cell medicine business divisions. The cosmetic business division provides cosmetics which contain stem cell culture medium.